Resideo insider may sell 47K shares, near $1M

Resideo Technologies, Inc. insider(s) filed a notice of proposed sale of 47,000 shares of common stock, to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE on or after August 17, 2026.

Rhea-AI Filing Summary

Resideo Technologies, Inc. insider(s) filed a notice of proposed sale of 47,000 shares of common stock, to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE on or after August 17, 2026. The filing lists an approximate aggregate market value of $999,741.70 for these shares. The shares trace to multiple issuer equity awards, including restricted stock and performance shares granted between September 29, 2023 and February 9, 2025.

Key Figures

Shares Proposed to Be Sold: 47,000 shares Approximate Aggregate Market Value: $999,741.70 CUSIP: 151847378 +5 more

8 metrics

Shares Proposed to Be Sold 47,000 shares Common stock to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services

Approximate Aggregate Market Value $999,741.70 Estimated value of 47,000 shares proposed for sale

CUSIP 151847378 Security identifier for the common stock subject to the proposed sale

Proposed Sale Date 08/17/2026 Date from which shares may be sold on the NYSE under Rule 144

Restricted Stock Grant 1 1,854 shares Restricted stock from issuer with date 09/29/2023

Restricted Stock Grant 2 11,686 shares Restricted stock from issuer with date 02/14/2024

Restricted Stock Grant 3 7,657 shares Restricted stock from issuer with date 02/18/2024

Performance Shares Grant 4,128 shares Performance shares from issuer with date 02/09/2025

Key Terms

Form 144, Restricted Stock, Performance Shares, Executive Financial Services

4 terms

Form 144 regulatory

"144: Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock financial

"Common | 09/29/2023 | Restricted Stock | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Performance Shares financial

"Common | 02/09/2025 | Performance Shares | Issuer"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Resideo Technologies (REZI) disclose in this Form 144?

The filing reports a proposed sale of 47,000 shares of Resideo common stock with an estimated value of $999,741.70, to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on or after August 17, 2026.

How many REZI shares are proposed to be sold and through whom?

The notice covers 47,000 shares of Resideo common stock. The proposed sale is to be made through Morgan Stanley Smith Barney LLC Executive Financial Services, based at 1 New York Plaza, 8th Floor, New York, NY 10004.

What is the estimated market value of the REZI shares in this Form 144?

The filer reports an approximate aggregate market value of $999,741.70 for the 47,000 shares of Resideo common stock that may be sold on or after August 17, 2026 on the NYSE.

When can the proposed REZI share sale under this Form 144 occur?

The Form 144 specifies a proposed sale date of August 17, 2026. This date marks when the filer may begin selling the 47,000 shares of Resideo common stock on the NYSE, subject to applicable Rule 144 conditions.

What types of equity awards back the REZI shares in this Form 144?

The shares derive from issuer equity grants classified as Restricted Stock and Performance Shares, with acquisition or grant dates including September 29, 2023, February 14, 2024, February 18, 2024, February 9, 2024, February 5, 2025, and February 9, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/17/2026 - 04:25 PM Accepted by SEC EDGAR 08/17/2026 - 04:24 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001754267
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	RESIDEO TECHNOLOGIES, INC.
SEC File Number	001-38635
Address of Issuer	16100 N. 71st Street, Suite 450, Scottsdale ARIZONA 85254
Phone	(480) 573-5340
Name of Person for Whose Account the Securities are To Be Sold	ROBERT AARNES
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	47000	999741.70	151847378	08/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/29/2023	Restricted Stock	Issuer			1854	09/29/2023	Not Applicable
Common	02/14/2024	Restricted Stock	Issuer			11686	02/14/2024	Not Applicable
Common	02/18/2024	Restricted Stock	Issuer			7657	02/18/2024	Not Applicable
Common	02/09/2024	Restricted Stock	Issuer			8844	02/09/2024	Not Applicable
Common	02/05/2025	Restricted Stock	Issuer			12831	02/05/2025	Not Applicable
Common	02/09/2025	Performance Shares	Issuer			4128	02/09/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Robert B Aarnes
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)